GSK PLC logo

GSK PLC

ARS 2285.50 (+1.58%) Sep 30
On watch
P/E:
11.62
P/B:
3.24
Market Cap:
ARS 8.72T ($ 59.21B)
Enterprise V:
ARS 11.28T ($ 76.58B)
Volume:
428.00
Avg Vol (2M):
691.00
Also Trade In:
Volume:
428.00
Market Cap ARS:
8.72T
Market Cap $:
59.21B
PE Ratio:
11.62
Avg Vol (2-Month):
691.00
Enterprise Value ARS:
11.28T
Enterprise Value $:
76.58B
PB Ratio:
3.24
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Financials (Next Earnings Date:2022-11-02)

BUE:GSK's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ARS) 4,908,926.635
EPS (TTM) (ARS) 78.469
Beta 0
Volatility % 45.21
14-Day RSI 43.78
14-Day ATR (ARS) 71.148118
20-Day SMA (ARS) 2275.425
12-1 Month Momentum % 4.51
52-Week Range (ARS) 2171.5 - 4028.75
Shares Outstanding (Mil) 8,134.74

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

GSK PLC Filings

Document Form Filing Date
No Filing Data

GSK PLC Analysis

Share your research